Torrent Pharmaceuticals has redeemed and repaid Commercial Paper worth Rs 200 crore on September 16, 2019. The instrument was issued on May 03, 2019.
Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.